330 related articles for article (PubMed ID: 19464461)
1. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery.
Frässdorf J; Borowski A; Ebel D; Feindt P; Hermes M; Meemann T; Weber R; Müllenheim J; Weber NC; Preckel B; Schlack W
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1436-42, 1442.e1-2. PubMed ID: 19464461
[TBL] [Abstract][Full Text] [Related]
2. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol.
Bein B; Renner J; Caliebe D; Hanss R; Bauer M; Fraund S; Scholz J
Anaesthesia; 2008 Oct; 63(10):1046-55. PubMed ID: 18627368
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study.
Yildirim V; Doganci S; Aydin A; Bolcal C; Demirkilic U; Cosar A
Heart Surg Forum; 2009 Jan; 12(1):E1-9. PubMed ID: 19233758
[TBL] [Abstract][Full Text] [Related]
4. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.
Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D
Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858
[TBL] [Abstract][Full Text] [Related]
5. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia.
Law-Koune JD; Raynaud C; Liu N; Dubois C; Romano M; Fischler M
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):484-92. PubMed ID: 16884977
[TBL] [Abstract][Full Text] [Related]
7. Sevoflurane-fentanyl versus etomidate-fentanyl for anesthetic induction in coronary artery bypass graft surgery patients.
Cheong KF; Choy JM
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):421-4. PubMed ID: 10972608
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration.
De Hert SG; Van der Linden PJ; Cromheecke S; Meeus R; Nelis A; Van Reeth V; ten Broecke PW; De Blier IG; Stockman BA; Rodrigus IE
Anesthesiology; 2004 Aug; 101(2):299-310. PubMed ID: 15277911
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass.
Cromheecke S; Pepermans V; Hendrickx E; Lorsomradee S; Ten Broecke PW; Stockman BA; Rodrigus IE; De Hert SG
Anesth Analg; 2006 Aug; 103(2):289-96, table of contents. PubMed ID: 16861404
[TBL] [Abstract][Full Text] [Related]
10. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery.
Kawamura T; Kadosaki M; Nara N; Kaise A; Suzuki H; Endo S; Wei J; Inada K
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):503-8. PubMed ID: 16884979
[TBL] [Abstract][Full Text] [Related]
11. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery.
Lorsomradee S; Cromheecke S; Lorsomradee S; De Hert SG
J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):684-90. PubMed ID: 17023289
[TBL] [Abstract][Full Text] [Related]
12. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.
Guarracino F; Landoni G; Tritapepe L; Pompei F; Leoni A; Aletti G; Scandroglio AM; Maselli D; De Luca M; Marchetti C; Crescenzi G; Zangrillo A
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):477-83. PubMed ID: 16884976
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin preconditioning in coronary artery bypass grafting.
Wei M; Wang X; Kuukasjärvi P; Laurikka J; Rinne T; Honkonen EL; Tarkka M
Ann Thorac Surg; 2004 Aug; 78(2):492-7. PubMed ID: 15276504
[TBL] [Abstract][Full Text] [Related]
14. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Tritapepe L; Landoni G; Guarracino F; Pompei F; Crivellari M; Maselli D; De Luca M; Fochi O; D'Avolio S; Bignami E; Calabrò MG; Zangrillo A
Eur J Anaesthesiol; 2007 Apr; 24(4):323-31. PubMed ID: 17156509
[TBL] [Abstract][Full Text] [Related]
15. The protective effects of preconditioning decline in aged patients undergoing coronary artery bypass grafting.
Wu ZK; Pehkonen E; Laurikka J; Kaukinen L; Honkonen EL; Kaukinen S; Laippala P; Tarkka MR
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):972-8. PubMed ID: 11689803
[TBL] [Abstract][Full Text] [Related]
16. Cardiac protection with volatile anesthetics in stenting procedures.
Landoni G; Zangrillo A; Fochi O; Maj G; Scandroglio AM; Morelli A; Tritapepe L; Montorfano M; Colombo A
J Cardiothorac Vasc Anesth; 2008 Aug; 22(4):543-7. PubMed ID: 18662628
[TBL] [Abstract][Full Text] [Related]
17. [Adenosine preconditioning reduces myocardial injury in patients undergoing off-pump coronary artery bypass grafting surgery].
Yang J; Li LH
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2313-5. PubMed ID: 18036291
[TBL] [Abstract][Full Text] [Related]
18. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
Kottenberg E; Thielmann M; Bergmann L; Heine T; Jakob H; Heusch G; Peters J
Acta Anaesthesiol Scand; 2012 Jan; 56(1):30-8. PubMed ID: 22103808
[TBL] [Abstract][Full Text] [Related]
19. Effect of Xenon Anesthesia Compared to Sevoflurane and Total Intravenous Anesthesia for Coronary Artery Bypass Graft Surgery on Postoperative Cardiac Troponin Release: An International, Multicenter, Phase 3, Single-blinded, Randomized Noninferiority Trial.
Hofland J; Ouattara A; Fellahi JL; Gruenewald M; Hazebroucq J; Ecoffey C; Joseph P; Heringlake M; Steib A; Coburn M; Amour J; Rozec B; Liefde I; Meybohm P; Preckel B; Hanouz JL; Tritapepe L; Tonner P; Benhaoua H; Roesner JP; Bein B; Hanouz L; Tenbrinck R; Bogers AJJC; Mik BG; Coiffic A; Renner J; Steinfath M; Francksen H; Broch O; Haneya A; Schaller M; Guinet P; Daviet L; Brianchon C; Rosier S; Lehot JJ; Paarmann H; Schön J; Hanke T; Ettel J; Olsson S; Klotz S; Samet A; Laurinenas G; Thibaud A; Cristinar M; Collanges O; Levy F; Rossaint R; Stevanovic A; Schaelte G; Stoppe C; Hamou NA; Hariri S; Quessard A; Carillion A; Morin H; Silleran J; Robert D; Crouzet AS; Zacharowski K; Reyher C; Iken S; Weber NC; Hollmann M; Eberl S; Carriero G; Collacchi D; Di Persio A; Fourcade O; Bergt S; Alms A;
Anesthesiology; 2017 Dec; 127(6):918-933. PubMed ID: 28872484
[TBL] [Abstract][Full Text] [Related]
20. Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
Ansley DM; Raedschelders K; Chen DD; Choi PT
Contemp Clin Trials; 2009 Jul; 30(4):380-5. PubMed ID: 19336262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
